Laurel Wealth Advisors (North Carolina)’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-160
| Closed | -$13K | – | 542 |
|
|
2022
Q2 | $13K | Hold |
160
| – | – | ﹤0.01% | 366 |
|
|
2022
Q1 | $12K | Hold |
160
| – | – | ﹤0.01% | 388 |
|
|
2021
Q4 | $14K | Hold |
160
| – | – | ﹤0.01% | 376 |
|
|
2021
Q3 | $12K | Hold |
160
| – | – | ﹤0.01% | 391 |
|
|
2021
Q2 | $13K | Hold |
160
| – | – | ﹤0.01% | 427 |
|
|
2021
Q1 | $12K | Buy |
160
+40
| +33% | +$3K | ﹤0.01% | 402 |
|
|
2020
Q4 | $11K | Buy |
+120
| New | +$11K | ﹤0.01% | 401 |
|